Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Novartis
US Department of Justice
Julphar
Fuji
Harvard Business School
Merck
Federal Trade Commission
McKesson
US Army

Generated: October 23, 2017

DrugPatentWatch Database Preview

PROLIXIN Drug Profile

« Back to Dashboard

What is the patent landscape for Prolixin, and what generic Prolixin alternatives are available?

Prolixin is a drug marketed by Apothecon and Bristol Myers Squibb and is included in five NDAs.

The generic ingredient in PROLIXIN is fluphenazine enanthate. There are eighteen drug master file entries for this compound. Additional details are available on the fluphenazine enanthate profile page.

Summary for Tradename: PROLIXIN

US Patents:0
Applicants:2
NDAs:5
Bulk Api Vendors: see list64
Patent Applications: see list3,884
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PROLIXIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon
PROLIXIN
fluphenazine hydrochloride
CONCENTRATE;ORAL070533-001Nov 7, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
PROLIXIN
fluphenazine hydrochloride
TABLET;ORAL011751-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
PROLIXIN
fluphenazine hydrochloride
TABLET;ORAL011751-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers Squibb
PROLIXIN DECANOATE
fluphenazine decanoate
INJECTABLE;INJECTION016727-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Apothecon
PROLIXIN
fluphenazine hydrochloride
ELIXIR;ORAL012145-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Apothecon
PROLIXIN
fluphenazine hydrochloride
INJECTABLE;INJECTION011751-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
PROLIXIN
fluphenazine hydrochloride
TABLET;ORAL011751-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
PROLIXIN
fluphenazine hydrochloride
TABLET;ORAL011751-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
PROLIXIN ENANTHATE
fluphenazine enanthate
INJECTABLE;INJECTION016110-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Dow
Medtronic
US Army
Baxter
Julphar
McKesson
Merck
QuintilesIMS
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot